Lumentum Holdings Inc. Work in process increased by 6.3% to $224.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 59.2%, from $141.20M to $224.80M. Over 4 years (FY 2021 to FY 2025), Work in process shows an upward trend with a 19.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $79.00M | $85.40M | $86.90M | $99.80M | $92.20M | $133.30M | $118.90M | $122.20M | $103.20M | $113.40M | $117.40M | $114.10M | $101.60M | $119.10M | $121.50M | $141.20M | $159.10M | $230.50M | $211.40M | $224.80M |
| QoQ Change | — | +8.1% | +1.8% | +14.8% | -7.6% | +44.6% | -10.8% | +2.8% | -15.5% | +9.9% | +3.5% | -2.8% | -11.0% | +17.2% | +2.0% | +16.2% | +12.7% | +44.9% | -8.3% | +6.3% |
| YoY Change | — | — | — | — | +16.7% | +56.1% | +36.8% | +22.4% | +11.9% | -14.9% | -1.3% | -6.6% | -1.6% | +5.0% | +3.5% | +23.8% | +56.6% | +93.5% | +74.0% | +59.2% |
| % of Inventories | 40.2% | 41.3% | 41.8% | 44.6% | 36.9% | 36.4% | 32.4% | 29.8% | 25.3% | 26.5% | 24.9% | 27.1% | 25.5% | 29.5% | 30.2% | 33.4% | 33.8% | 43.4% | 37.1% | 35.5% |
| Share Change | — | +1.0pp | +0.5pp | +2.8pp | -7.7pp | -0.5pp | -4.0pp | -2.6pp | -4.5pp | +1.2pp | -1.6pp | +2.2pp | -1.6pp | +4.0pp | +0.7pp | +3.2pp | +0.5pp | +9.5pp | -6.3pp | -1.5pp |